Sou Hu Cai Jing·2025-12-13 03:44Group 1: Investment and Financing Activities - Shanghai Zhishi Robotics completed A+ round financing of several tens of millions, exclusively invested by Yinfeng Capital, focusing on four-way shuttle robots for automated storage solutions [2] - Wuhan Jizhao Energy Technology announced the completion of several tens of millions in angel+ round financing led by Guanghe Venture Capital, aimed at supporting the delivery of the world's first MW-level liquid metal battery energy storage system [2] - Deep Intelligent Pharma announced nearly $50 million in D round financing led by Dinghui Baifu, with participation from existing shareholders, to enhance AI-driven drug development [4] - Deshengji Pharmaceutical completed $108 million in B round financing, with investors including IDG Capital and Sequoia China, focusing on precision therapeutic drug development [5] - Skild AI is in negotiations for over $1 billion investment from SoftBank and NVIDIA, potentially increasing its valuation to approximately $14 billion [6] - Pruy Benchmark completed over $10 million in new financing, focusing on AI-driven drug research and development [7] Group 2: Company Developments and Innovations - Zhishi Robotics aims to enhance storage density and efficiency in warehouses through innovative four-way shuttle technology [2] - Jizhao Energy is the first domestic supplier of liquid metal battery energy storage systems, with a pilot production line established for various battery products [2] - Shenzhen Zhaqi Xinzhi focuses on creating a high-throughput, low-cost protein detection platform using semiconductor technology [4] - Skild AI, founded by former Meta AI researchers, aims to develop general AI software systems for robotics, enhancing their perception and decision-making capabilities [6] - Pruy Benchmark leverages multi-omics and AI algorithms to support drug mechanism research and biomarker development [7]